NARA ORGANICS RECALLS ALL LOTS OF NARA INFANT FORMULA BECAUSE OF POSSIBLE HEALTH RISK

Pensacola, Fl. NewsWK — Out of an abundance of caution, Nara Organics of New York, NY, has announced a voluntary nationwide recall of all lots of its Powdered Infant Formula currently on the market. The recall follows an advisory from federal health agencies regarding a potential risk of Clostridium botulinum contamination.

The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) contacted Nara Organics late Friday, June 12, 2026, after three cases of infant botulism were reported. The CDC indicated that the three affected infants had consumed Nara formula. The infants were subsequently hospitalized and treated with Botulism Immune Globulin Intravenous (BabyBIG) in California, Washington, and Pennsylvania. No deaths have been reported.

To date, Nara infant formula has not tested positive for C. botulinum. However, the company is recalling all products currently in the market as they work alongside the FDA, CDC, and state partners to investigate the root causes of the illnesses.

Summary

Company Announcement Date:June 13, 2026FDA Publish Date:June 13, 2026Product Type:Food & BeveragesReason for Announcement:

Potential risk of Clostridium botulinum contamination.Company Name:Nara OrganicsBrand Name:

Nara OrganicsProduct Description:

Whole Milk Powdered Infant Formula

Company Announcement

Nara Organics of New York, NY, is voluntarily recalling all lots of Nara Organics Powdered Infant Formula currently on the market out of an abundance of caution due to the potential risk of Clostridium botulinum contamination.

Infant botulism is a rare but potentially fatal illness that presents a serious threat to the health of infants which occurs when Clostridium botulinum spores are ingested and colonize the intestinal tract, producing botulinum neurotoxins in the immature gut of infants. Affected infants can present with some or all of the following signs and symptoms: constipation, poor feeding, ptosis (drooping eyelid), sluggish pupils, low muscle tone, difficulty sucking and swallowing, weak or altered cry, generalized weakness, respiratory difficulty, and possibly respiratory arrest.

Nara Organics Powdered Infant Formula was distributed nationally across Target retail stores, Target.com, and Nara.com between July 2025 and June 2026. Nara Infant Formula is not distributed outside of the USA.

Affected Product Details:

• Nara Organics Whole Milk Infant Formula, 700g, with UPC 860013251901
• Nara Organics Whole Milk Infant Formula, 400g, with UPC: 860013251918

All lots currently on the market are included in this voluntary recall, and the specific codes are as follows. The lot code can be found on the bottom of each can.

• 408125075E14F2
• 708125076E14F2
• 708125083E14F2
• 408125139E14F2
• 708125141E14F2
• 708125145E14F2
• 708125174E14F2
• 709125273E14F2
• 709125280E14F2
• 709125288E14F2
• 409125307E14F2
• 70926019ENNB
• 70926029ENNB
• 70926035ENNB
• 70926039ENNB
• 70926042ENNB

The Food and Drug Administration (FDA) and Center for Disease Control (CDC) contacted Nara Organics late Friday, June 12, 2026, and provided information about 3 cases of infant botulism in infants who CDC reported had consumed Nara formula. The 3 infants were hospitalized and treated with BabyBIG (Botulism Immune Globulin Intravenous) in California, Washington, and Pennsylvania. There are no reported deaths. The three specific product lots these infants were exposed to are: 709125280E14F2, 709125288E14F2, 708125174E14F2. To date, Nara infant formula has not tested positive for C. botulinum. However, Nara is voluntarily recalling all products currently in market.

Nara is taking aggressive action to ensure the safety of the babies and families who use the product as we work closely with the FDA, Centers for Disease Control and Prevention (CDC), and state partners to support their investigation into the root causes of these cases.

Customers should stop using the affected products immediately. If your baby has consumed this product and is presenting symptoms of infant botulism including, but not limited to vomiting, diarrhea, constipation, poor feeding, drooping eyelids, and weak crying, please contact your healthcare provider for immediate care.

To report an illness or adverse event, you can:

• Report a Product Problem through SmartHub
• Complete an electronic Voluntary MedWatch form online
• Complete a paper Voluntary MedWatch form that can be mailed to FDA

Nara will automatically refund all consumers who purchased formula from their website in May and June 2026. Other customers with unused product may request a refund by taking a photo of the bottom of each can and completing the refund form here:

https://nara.com/pages/refund-request-formExternal Link Disclaimer. Target customers may return their product to Target retail locations or follow Target’s online return instructions.

We sincerely apologize for the concern and distress this announcement causes our customers. We are committed to leading with transparency and accountability throughout this process as we work to identify further information. We will provide additional information as it becomes available. Customers with questions are encouraged to visit Nara’s website External Link Disclaimeror email hello@nara.com.

FDA Outbreak Advisory

Company Contact Information

Consumers: hello@nara.comMedia: media@nara.com